PHI Pharmacist : DR-TB TREATMENT AND CARE
- Drug-Resistant Tuberculosis(DR-TB)
- Goals of DR-TB Treatment
- Screening for DR-TB
- Types of Drug Resistance Tuberculosis -DRTB
- DR-TB Treatment Regimens
- Pre-treatment Evaluation [PTE] of DR-TB Patients
- Second Line anti TB drugs
- Newer Anti-TB Drugs
- Weight Band-wise Dosages of DR-TB Drugs for Adults
- Treatment of DR-TB in Children
- Adverse Drug Reactions(ADRs) to Second Line Treatment
- Reporting of Adverse Events and Serious Adverse Events
PHI-Pharmacist: TB and TB Epidemiology
- Tuberculosis
- Global Burden of TB
- Burden of TB in India
- TB Causative organism
- Mode of TB Transmission
- Determinants of TB Disease
- Vulnerable Population for Tuberculosis
- TB Infection
- Progression to TB Disease
- TB Infection Vs Active TB Disease
- Chemotherapy and its implication in TB control
- Prevention of TB
CDST_LT: LPA Troubleshooting and quality assurance
- LPA Troubleshooting for No Signal
- LPA Troubleshooting for No Signal Except Conjugate Control [CC]
- LPA Troubleshooting for Uneven Staining
- LPA Troubleshooting for High Background Colour
- LPA Troubleshooting for Other Possible Reasons
- LPA Quality Assurance [QA] Including Quality Control
- LPA Procedural Quality Control
- LPA Quality Assurance: Proficiency Testing
- LPA Quality Assurance: Cleaning of Lab
CDST_LT: LPA Recording, interpretation and reporting
- Interpretation of FL-LPA: Examples of Test Results Interpretation
- Evaluation of First-line Line Probe Assay Strip
- Evaluation of Second-line Line Probe Assay Strip
- Interpretation of FL-LPA: Predicting TB Drug-resistance
- Interpretation of FL-LPA: Predicting Drug-resistance in Special Cases
- Interpretation of FL-LPA: Examples of Test Results Interpretation
- Limitations of First-line Line Probe Assay [FL-LPA]
- Reporting First-line Line Probe Assay [FL-LPA] Results
- Reporting the Result of First-line Line Probe Assay [FL-LPA] in Special Cases
- Interpretation of SL-LPA: Predicting Drug Resistance
- Interpretation of SL-LPA: Predicting Drug resistance in Special Cases
- Interpretation of SL-LPA: Interpretation Examples
- Limitations of Second-line Line Probe Assay [SL-LPA]
- Reporting Second Line-Line Probe Assay [SL-LPA] Results
CDST_LT: LPA procedures
- Specimen Preparation for LC and LPA Labs
- Extraction of DNA from Smear Positive Clinical Specimen, LJ and Liquid Media in LPA Lab Settings
- Contamination Control During DNA Extraction in LPA Lab Settings
- LPA PCR Reagent Preparation: Test Reagents Kit
- PCR Reagent Preparation Procedure in the LPA Lab
- Contamination Control During PCR Reagent Preparation in the LPA Lab
- Amplification of Extracted DNA in the LPA Lab
- Contamination Control in the Amplification Room in the LPA Lab
- Overview of Hybridization in Line Probe Assay and Genotypic Drug Sensitivity Testing
- Hybridization Setup in LPA and Genotypic DST
- Hybridization Using Twincubator in LPA Lab Settings
- Hybridization Using GT BLOT in LPA Lab Settings
- Contamination Control in the Hybridization Area in LPA Lab Settings